DE3689769T2 - Multilamellare liposome mit verbesserter einschliessungswirkung. - Google Patents

Multilamellare liposome mit verbesserter einschliessungswirkung.

Info

Publication number
DE3689769T2
DE3689769T2 DE3689769T DE3689769T DE3689769T2 DE 3689769 T2 DE3689769 T2 DE 3689769T2 DE 3689769 T DE3689769 T DE 3689769T DE 3689769 T DE3689769 T DE 3689769T DE 3689769 T2 DE3689769 T2 DE 3689769T2
Authority
DE
Germany
Prior art keywords
including effect
multilamellar liposome
improved including
improved
multilamellar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3689769T
Other languages
English (en)
Other versions
DE3689769D1 (de
Inventor
Marcel Bally
Pieter Cullis
Michael Hope
Andrew Janoff
Lawrence Mayer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharmaceuticals LLC
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Application granted granted Critical
Publication of DE3689769D1 publication Critical patent/DE3689769D1/de
Publication of DE3689769T2 publication Critical patent/DE3689769T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
DE3689769T 1985-07-05 1986-06-24 Multilamellare liposome mit verbesserter einschliessungswirkung. Expired - Fee Related DE3689769T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75242385A 1985-07-05 1985-07-05
US80054585A 1985-11-21 1985-11-21
PCT/US1986/001371 WO1987000043A1 (en) 1985-07-05 1986-06-24 Multilamellar liposomes having improved trapping efficiencies

Publications (2)

Publication Number Publication Date
DE3689769D1 DE3689769D1 (de) 1994-05-11
DE3689769T2 true DE3689769T2 (de) 1994-07-21

Family

ID=27115587

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3689769T Expired - Fee Related DE3689769T2 (de) 1985-07-05 1986-06-24 Multilamellare liposome mit verbesserter einschliessungswirkung.

Country Status (4)

Country Link
EP (1) EP0231261B1 (de)
JP (2) JP2579625B2 (de)
DE (1) DE3689769T2 (de)
WO (1) WO1987000043A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897873A (en) * 1984-04-12 1999-04-27 The Liposome Company, Inc. Affinity associated vaccine
US5204112A (en) * 1986-06-16 1993-04-20 The Liposome Company, Inc. Induction of asymmetry in vesicles
US5252263A (en) * 1986-06-16 1993-10-12 The Liposome Company, Inc. Induction of asymmetry in vesicles
US4963297A (en) * 1987-12-22 1990-10-16 The Liposome Company, Inc. Spontaneous vesticulation of multilamellar liposomes
JPH02502978A (ja) * 1987-04-16 1990-09-20 ザ　リポソーム　カンパニー，インコーポレイテッド リポソームの連続的サイズ減少方法及び装置
US5082664A (en) * 1987-05-22 1992-01-21 The Liposome Company, Inc. Prostaglandin-lipid formulations
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
US5262168A (en) * 1987-05-22 1993-11-16 The Liposome Company, Inc. Prostaglandin-lipid formulations
MX9203804A (es) * 1987-10-19 1992-07-01 Liposome Co Inc Sistemas farmaceuticos a base de tocoferol.
US5948441A (en) * 1988-03-07 1999-09-07 The Liposome Company, Inc. Method for size separation of particles
BE1001869A3 (fr) * 1988-10-12 1990-04-03 Franz Legros Procede d'encapsulation liposomiale d'antibiotiques aminoglucosidiques, en particulier de la gentamycine.
US5049392A (en) * 1989-01-18 1991-09-17 The Liposome Company, Inc. Osmotically dependent vesicles
US5100662A (en) * 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
US5820848A (en) * 1990-01-12 1998-10-13 The Liposome Company, Inc. Methods of preparing interdigitation-fusion liposomes and gels which encapsulate a bioactive agent
US5525232A (en) * 1990-03-02 1996-06-11 The Liposome Company, Inc. Method for entrapment of cationic species in lemellar vesicles
DK148292D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Forbindelser
WO1994027580A1 (en) * 1993-05-21 1994-12-08 The Liposome Company, Inc. Reduction of liposome-induced adverse physiological reactions
CA2126648C (en) * 1993-11-09 2000-10-10 Tomas De Paoli Liposomes containing bioavailable iron (ii) and method for obtaining them
US5902604A (en) * 1995-06-06 1999-05-11 Board Of Regents, The University Of Texas System Submicron liposome suspensions obtained from preliposome lyophilizates
ATE243998T1 (de) 1995-10-12 2003-07-15 Supergen Inc Liposomformulierung von 5-beta steroiden
US6613352B2 (en) 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
ES2275443B1 (es) * 2005-11-30 2008-06-01 Italfarmaco, S.A. Procedimiento de preparacion de liposomas.
LT1962805T (lt) 2005-12-08 2016-10-25 Insmed Incorporated Antiinfekcinės lipidų pagrindo kompozicijos, skirtos plaučių infekcijų gydymui
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
CN108743537B (zh) 2012-05-21 2021-06-11 英斯麦德公司 治疗肺部感染的系统
RU2675859C2 (ru) 2012-11-29 2018-12-25 Инсмед Инкорпорейтед Стабилизированные составы ванкомицина
EP3142643B1 (de) 2014-05-15 2019-07-10 Insmed Incorporated Verfahren zur behandlung von pulmonaler mykobakterieller nichttuberkuloseinfektionen
WO2019191627A1 (en) 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
EP4312536A1 (de) 2021-04-01 2024-02-07 Vestaron Corporation Liposomformulierungen zur pestizidabgabe und verfahren zur herstellung und verwendung davon

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
JPS5492951A (en) * 1977-12-29 1979-07-23 Shionogi & Co Ltd Novel aminoglycoside derivative
JPS558488A (en) * 1978-07-05 1980-01-22 Mitsubishi Electric Corp Surface treating method of radiator
US4397846A (en) * 1981-05-15 1983-08-09 Murray Weiner Storage-stable lipid vesicles and method of preparation
AU564876B2 (en) * 1982-03-29 1987-08-27 Liposome Company, Inc., The Stable plurilamellar vesicles
US4515736A (en) * 1983-05-12 1985-05-07 The Regents Of The University Of California Method for encapsulating materials into liposomes
CA1237671A (en) * 1983-08-01 1988-06-07 Michael W. Fountain Enhancement of pharmaceutical activity
US4532089A (en) * 1984-01-14 1985-07-30 Northwestern University Method of preparing giant size liposomes
GB8407557D0 (en) * 1984-03-23 1984-05-02 Hayward J A Polymeric lipsomes
JPS6150912A (ja) * 1984-08-16 1986-03-13 Shionogi & Co Ltd リポソ−ム製剤の製造法

Also Published As

Publication number Publication date
EP0231261A4 (de) 1988-04-27
JP2579625B2 (ja) 1997-02-05
JP2566747B2 (ja) 1996-12-25
JPS63500798A (ja) 1988-03-24
EP0231261B1 (de) 1994-04-06
WO1987000043A1 (en) 1987-01-15
EP0231261A1 (de) 1987-08-12
JPH08175975A (ja) 1996-07-09
DE3689769D1 (de) 1994-05-11

Similar Documents

Publication Publication Date Title
DE3689769T2 (de) Multilamellare liposome mit verbesserter einschliessungswirkung.
DE3772385D1 (de) Liposome mit gesteigerter zirkulationszeit.
PT83960B (pt) Fralda descartavel com fixacao aperfeicoada
DE3678913D1 (de) Zubereitung mit in liposome eingeschlossenem adriamycin.
FI864467A (fi) Brandhaerdig vaeggkonstruktion.
DE3586242T2 (de) Steroid-liposome.
DE3585967D1 (de) Liposombildende zusammensetzung.
NO162226C (no) Opprullingsanordning.
DK354886A (da) Mikroemulsionsmidler
DE3584850D1 (de) Liposome-zusammensetzung.
DE3675039D1 (de) Polsterungsteil.
DE3584446D1 (de) Mikroprozessor.
FI852945A0 (fi) Foerstyvat skaerblad med svaengbar och utbytbar egg.
NL191371C (nl) Ruimtelijk gestel.
FI862717A (fi) Foerbaettrat kollagenkorvskal.
IT1186733B (it) Composti tripeptidici ad azione ipotensiva
KR870009196U (ko) 진압 로울러
ATE103802T1 (de) Multilamellare liposome mit verbesserter einschliessungswirkung.
IT1190383B (it) Sostanze peptidominetiche ad azione ipotensiva
NO865090D0 (no) Granat med kombinert effekt.
KR860010563U (ko) 계수기가 착설된 지철기
ATE63686T1 (de) Stabile liposome mit wasserloeslichen arzneimitteln.
DE3667851D1 (de) Verbessertes pyrgeometer.
ES288550Y (es) Refuerzo para sillas
FI853589A0 (fi) Elektrisk ugn.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee